For more than four decades, MZF4 Medical has built its reputation as a trusted manufacturer of high-performance implantable sutures, supplying orthopedic and medical device companies in more than 40 countries. Throughout this journey, the company has continuously invested in engineering excellence, manufacturing precision and close collaboration with global OEM partners, establishing itself as one of the most respected independent manufacturers in its field.
Today, while implantable futures remain one of the company’s core businesses, MZF4 Medical is entering a new phase of its evolution.
Rather than redefining its identity, the company is expanding the engineering expertise developed over decades in advanced textile manufacturing to create a broader innovation platform dedicated to implantable textile structures for Sports Medicine, Orthopedics, Cardiovascular Surgery, General Surgery and other high-value medical applications.
This strategic evolution will be one of the highlights presented during Medtec China 2026, one of Asia’s leading exhibitions for medical device technologies, manufacturing and supply chain solutions.
“Our history was built on implantable sutures, and they will continue to be one of the foundations of our business,” says Claudio Mazzaferro, CEO of MZF4 Medical.
“What is evolving is the scope of our engineering capabilities. The same knowledge that allowed us to manufacture millions of high-performance implantable sutures is now enabling us to develop increasingly sophisticated textile structures for the next generation of medical devices.”
This evolution is supported by the company’s new innovation platform, which combines advanced textile engineering, biomaterials, manufacturing technologies and collaborative product development.
Instead of simply supplying products, MZF4 Medical increasingly works alongside OEM partners from the earliest stages of development, creating customized implantable solutions designed around each customer’s clinical, mechanical and manufacturing requirements.
Among the technologies that illustrate this new phase are specialized development platforms for Conical Sutures, Variable Programming Sutures, Hybrid Material Structures, Bifurcated and Quadrifurcated Textile Systems, Artificial Ligament Technologies and other customized implantable textile architectures.
To support this strategy, MZF4 Medical continues investing in advanced manufacturing capabilities, automation, process validation and its recently expanded textile development platform, allowing rapid prototyping and industrialization of increasingly complex medical devices.
According to Ana Luiza De Rosa, Innovation & R&D Manager, the company’s future is being built by combining textile expertise with collaborative engineering.
“Everything starts with textile engineering. Once you master fibers, braiding technologies, materials and manufacturing processes, you can create far more than sutures. Today we work together with our customers to develop customized implantable textile structures that combine engineering, biomaterials and advanced manufacturing to solve increasingly complex clinical challenges.”
Participation in Medtec China also reinforces MZF4 Medical’s long-term commitment to strengthening relationships with suppliers, technology companies, biomaterial developers and OEM customers throughout Asia, one of the world’s fastest-growing centers for medical device innovation.
“Our objective is not only to exhibit products,” adds Mazzaferro.
“We want to build long-term partnerships. Innovation increasingly happens through collaboration, and our ambition is to become a preferred engineering and manufacturing partner for companies seeking differentiated implantable solutions.”
Visitors attending Medtec China 2026 will have the opportunity to discover both dimensions of MZF4 Medical: a company with decades of expertise in implantable sutures and a rapidly evolving engineering platform developing the next generation of implantable textile structures for the global medical device industry.
About MZF4 Medical
MZF4 Medical is a Brazilian manufacturer specializing in implantable sutures, orthopedic devices and advanced implantable textile structures. Combining textile engineering, biomaterials, precision manufacturing and collaborative product development, the company partners with leading medical device manufacturers worldwide transform engineering concepts into reliable, high-performance medical solutions. Serving customers in more than 40 countries, MZF4 Medical continues expanding its global presence while investing in innovation, quality and manufacturing excellence.(June, 27th 2026)